Showing 521-530 of 534 results for "".
- Imprimis to Feature its Cyclosporine/Chondroitin Sulfate and Non-Opioid MKO Melt Formulations at the Upcoming ASCRS Meetinghttps://modernod.com/news/imprimis-to-feature-its-cyclosporine-chondroitin-sulfate-and-non-opioid-mko-melt-formulations-at-the-upcoming-ascrs-meeting/2480266/Imprimis Pharmaceuticals and its ophthalmology-focused ImprimisRx division announced its participation and related physician presentations at the 2018 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held at the Walter E. Washington Convention Center in Washington,
- FDA Clears Alcon's Unity Vitreoretinal-Cataract System and Standalone Cataract Systemhttps://modernod.com/news/fda-clears-alcons-unity-vitreoretinal-cataract-system-and-unity-standalone-cataract-system/2482329/Alcon announced that its Unity Vitreoretinal Cataract System (VCS) and Unity Cataract System (CS) have received FDA 510(k) clearance. The new devices are the first to be introduced from Alcon’s Unity portfolio and represent Alcon's next generation of e
- ScienceBased Health Welcomes New Members to Its Optometry Clinical Advisory Panelhttps://modernod.com/news/sciencebased-health-welcomes-new-members-to-its-optometry-clinical-advisory-panel/2481787/ScienceBased Health (SBH) announced the addition of Jaclyn Garlich, OD, FAAO; Jacob Lang, OD, FAAO, Dipl ABO; and Mark Schaeffer, OD to its Optometry Clinical Advisory Panel. ScienceBased Health develops and markets e
- Staar Surgical Celebrates 2 Million Lens Milestone for Implantable Collamer Lens (ICL)https://modernod.com/news/staar-surgical-celebrates-2-million-lens-milestone-for-implantable-collamer-lens-icl/2480897/Staar Surgical announced that more than 2 million Visian Implantable Collamer lenses (ICLs) have been sold globally, including more than one and a half million of the company’s latest generation of implantable lenses–EVO Visian ICLs (EVO). New to the U.S. market, E
- Viatris Announces US Launch of Ryzumvi for the Reversal of Mydriasishttps://modernod.com/news/viatris-announces-us-launch-of-ryzumvi-for-the-reversal-of-mydriasis/2482191/Viatris and Ocuphire announced the US commercial launch of Ryzumvi (phentolamine ophthalmic solution) 0.75% for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents in the Uni
- Ocuphire Pharma and Viatris Receive FDA Approval of Ryzumvi for the Reversal of Pharmacologically-Induced Mydriasishttps://modernod.com/news/ocuphire-pharma-and-viatris-receive-fda-approval-of-ryzumvi-for-the-reversal-of-pharmacologically-induced-mydriasis/2481852/Ocuphire Pharma and Viatris announced that the FDA has approved Ryzumvi (phentolamine ophthalmic solution) 0.75% for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents.
- Ocuphire Pharma Submits New Drug Application to FDA for Nyxol Eye Drops for Reversal of Mydriasishttps://modernod.com/news/ocuphire-pharma-submits-new-drug-application-to-fda-for-nyxol-eye-drops-for-reversal-of-mydriasis/2481278/Ocuphire Pharma announced the submission of a new drug application (NDA) to the FDA for Phentolamine Ophthalmic Solution 0.75% (Nyxol) for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist (e.g., phenylephrine) or parasympatholytic (e.g., tropicamid
- Zeiss and Senorics Establish Partnership Focus on Joint Development of Sensor Technologyhttps://modernod.com/news/zeiss-and-senorics-establish-partnership-focus-on-joint-development-of-sensor-technology/2476952/Zeiss announced that it has invested in Dresden, Germany-based Senorics. The partnership aims to further the joint development of small and cost-effective sensors for industrial use in quality assurance and in process monitoring, e.g. on production lines for foodstuffs, agricultural products, pla
- Alan Reiderhttps://modernod.com/profiles/alan-reider/jGPAa5/
- Naureen M. Haroon, OD, MPH, FAAOhttps://modernod.com/profiles/naureen-m-haroon-od-mph-faao/OBB1nr/